| scholarly article | Q13442814 |
| P50 | author | Kangsheng Tu | Q85646952 |
| P2093 | author name string | Qing Li | |
| Wei Yang | |||
| Chao Li | |||
| Yufeng Wang | |||
| Changwei Dou | |||
| Qingguang Liu | |||
| Yuli Jia | |||
| Zhikui Liu | |||
| Yingmin Yao | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells | Q24615539 | ||
| Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221 | Q24631381 | ||
| Suppression of non-small cell lung tumor development by the let-7 microRNA family | Q24651985 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function | Q33557334 | ||
| Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma | Q33611696 | ||
| Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. | Q33673983 | ||
| The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism | Q34490202 | ||
| Retracted: Recombinant Human Adenovirus-p53 Injection Induced Apoptosis in Hepatocellular Carcinoma Cell Lines Mediated by p53-Fbxw7 Pathway, Which Controls c-Myc and Cyclin E | Q34809227 | ||
| FOXA1 is a potential oncogene in anaplastic thyroid carcinoma | Q34983133 | ||
| Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice | Q35086711 | ||
| MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. | Q35200832 | ||
| Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer | Q35697378 | ||
| The microcosmos of cancer | Q36432986 | ||
| Comprehensive microRNA Profiling of Prostate Cancer | Q36916050 | ||
| MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy | Q37660733 | ||
| The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. | Q37996436 | ||
| MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? | Q38053397 | ||
| The long and short of microRNA. | Q38102186 | ||
| miR-122--a key factor and therapeutic target in liver disease | Q38259438 | ||
| Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells | Q38952857 | ||
| YAP activation is an early event and a potential therapeutic target in liver cancer development. | Q38976729 | ||
| miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. | Q38981665 | ||
| MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase | Q38995250 | ||
| Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. | Q39095795 | ||
| MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. | Q39136095 | ||
| Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. | Q39167027 | ||
| Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer | Q39477817 | ||
| MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity | Q39893180 | ||
| FOXA1 is an independent prognostic marker for ER-positive breast cancer. | Q42486962 | ||
| miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. | Q45801517 | ||
| MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 | ||
| miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. | Q48061857 | ||
| Identification of metastasis-related microRNAs in hepatocellular carcinoma. | Q51897320 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 13216-13228 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1 | |
| P478 | volume | 6 |
| Q40242560 | A five-miRNA expression signature predicts survival in hepatocellular carcinoma |
| Q64259982 | A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis |
| Q54978003 | Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. |
| Q90618446 | Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk |
| Q38714300 | Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma |
| Q47269736 | HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. |
| Q40641258 | Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway |
| Q47136547 | Methylation of microRNA-129-5P modulates nucleus pulposus cell autophagy by targeting Beclin-1 in intervertebral disc degeneration |
| Q37392871 | Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma |
| Q37520274 | MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway |
| Q42371572 | MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma. |
| Q33792251 | MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway |
| Q52671363 | MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. |
| Q36375121 | MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. |
| Q39442968 | MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3. |
| Q40990557 | MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4 |
| Q47108462 | MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP). |
| Q35800562 | MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence |
| Q39013543 | MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1. |
| Q50102414 | MicroRNA-212 targets mitogen-activated protein kinase 1 to inhibit proliferation and invasion of prostate cancer cells |
| Q47098482 | MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1. |
| Q38809606 | MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition |
| Q36571466 | MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma |
| Q38827376 | MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor |
| Q37021257 | MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway |
| Q28072056 | MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers |
| Q47388075 | MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2. |
| Q64232742 | MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1 |
| Q41990459 | New Insights into the Epigenetics of Hepatocellular Carcinoma. |
| Q47096853 | Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis |
| Q52856031 | Restoration of microRNA-212 causes a G0/G1 cell cycle arrest and apoptosis in adult T-cell leukemia/lymphoma cells by repressing CCND3 expression. |
| Q37696983 | Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer |
| Q37190816 | The clinical significance of forkhead box protein A1 and its role in colorectal cancer |
| Q92598014 | The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy |
| Q52606808 | Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma. |
| Q51420219 | miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma. |
| Q37634229 | microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7. |
Search more.